What are analysts Suggestions on Grupo Financiero Galicia S.A.(NASDAQ:GGAL): Novavax, Inc.(NASDAQ:NVAX)

0
3

Grupo Financiero Galicia S.A. (GGAL) will report its next earnings on Aug 16. The company reported the earnings of $1.85/Share in the last quarter where the estimated EPS by analysts was $0.93/share. The difference between the expected and actual EPS was $0.92/share, which represents an Earnings surprise of 98.9%.

Many analysts are providing their Estimated Earnings analysis for Grupo Financiero Galicia S.A. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $0.82/share. These analysts have also projected a Low Estimate of $0.67/share and a High Estimate of $0.96/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Grupo Financiero Galicia S.A. as 532.51 Million. According to these analysts, the Low Revenue Estimate for Grupo Financiero Galicia S.A. is 497.97 Million and the High Revenue Estimate is 567.04 Million. The company had Year Ago Sales of 634.95 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for GGAL to be 7.4%. They are projecting Next Quarter growth of 25%. For the next 5 years, Grupo Financiero Galicia S.A. is expecting Growth of 4.89% per annum, whereas in the past 5 years the growth was 13.93% per annum.

Some buy side analysts are also providing their Analysis on Grupo Financiero Galicia S.A., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Grupo Financiero Galicia S.A. might touch $40 high while the Average Price Target and Low price Target is $28.35 and $14 respectively.

Grupo Financiero Galicia S.A. closed its last trading session at $11.73 with the gain of 0.6%. The Market Capitalization of the company stands at 1.49 Billion. The Company has 52-week high of $39.22 and 52-week low of $9.53. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -22.87% where SMA50 and SMA200 are -57.33% and -58.29% respectively. The Company Touched its 52-Week High on 07/10/19 and 52-Week Low on 09/03/19.

The Relative Volume of the company is 0.68 and Average Volume (3 months) is 2.41 million. The company’s P/E (price to earnings) ratio is 3.22 and Forward P/E ratio of 3.48.

The company shows its Return on Assets (ROA) value of 5%. The Return on Equity (ROE) value stands at 48.3%. While it’s Return on Investment (ROI) value is 12.5%.

While looking at the Stock’s Performance, Grupo Financiero Galicia S.A. currently shows a Weekly Performance of 8.86%, where Monthly Performance is -66.24%, Quarterly performance is -58.67%, 6 Months performance is -57.04% and yearly performance percentage is -51.84%. Year to Date performance value (YTD perf) value is -57.2%. The Stock currently has a Weekly Volatility of 12.89% and Monthly Volatility of 10.43%.

Novavax, Inc. (NVAX) will report its next earnings on Aug 07 AMC. The company reported the earnings of $-1.69/Share in the last quarter where the estimated EPS by analysts was $-1.61/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -5%.

Many analysts are providing their Estimated Earnings analysis for Novavax, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-1.23/share. These analysts have also projected a Low Estimate of $-2.2/share and a High Estimate of $-0.69/share.

These analysts also forecasted Growth Estimates for the Current Quarter for NVAX to be 63.3%. They are projecting Next Quarter growth of 55.77%. For the next 5 years, Novavax, Inc. is expecting Growth of 40.45% per annum, whereas in the past 5 years the growth was 44% per annum.

Some buy side analysts are also providing their Analysis on Novavax, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Novavax, Inc. might touch $42.5 high while the Average Price Target and Low price Target is $25.1 and $6 respectively.

Novavax, Inc. closed its last trading session at $5.5 with the loss of -1.09%. The Market Capitalization of the company stands at 125.39 Million. The Company has 52-week high of $51.60 and 52-week low of $4.01. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.1% where SMA50 and SMA200 are 3.12% and -71.35% respectively. The Company Touched its 52-Week High on 12/13/18 and 52-Week Low on 08/13/19.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 890.12 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -81.3%. The Return on Equity (ROE) value stands at 112.1%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Novavax, Inc. currently shows a Weekly Performance of -8.88%, where Monthly Performance is 24.49%, Quarterly performance is 1.3%, 6 Months performance is -46.55% and yearly performance percentage is -81.11%. Year to Date performance value (YTD perf) value is -85.22%. The Stock currently has a Weekly Volatility of 6.32% and Monthly Volatility of 11.05%.

SHARE